220 related articles for article (PubMed ID: 16760328)
1. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.
Samri A; Durier C; Urrutia A; Sanchez I; Gahery-Segard H; Imbart S; Sinet M; Tartour E; Aboulker JP; Autran B; Venet A;
Clin Vaccine Immunol; 2006 Jun; 13(6):684-97. PubMed ID: 16760328
[TBL] [Abstract][Full Text] [Related]
2. Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay.
Periwal SB; Spagna K; Shahabi V; Quiroz J; Shroff KE
J Immunol Methods; 2005 Oct; 305(2):128-34. PubMed ID: 16181634
[TBL] [Abstract][Full Text] [Related]
3. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
[TBL] [Abstract][Full Text] [Related]
5. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
Tang YB; Tang XP; Jin X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
[TBL] [Abstract][Full Text] [Related]
6. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines.
Mwau M; McMichael AJ; Hanke T
AIDS Res Hum Retroviruses; 2002 Jun; 18(9):611-8. PubMed ID: 12079556
[TBL] [Abstract][Full Text] [Related]
7. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
Eshofonie A; van der Loeff MS; Whittle H; Jaye A
Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
[TBL] [Abstract][Full Text] [Related]
8. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT.
Ryan JE; Ovsyannikova IG; Poland GA
Methods Mol Biol; 2005; 302():207-18. PubMed ID: 15937354
[TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
[TBL] [Abstract][Full Text] [Related]
11. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point.
Gray CM; Mlotshwa M; Riou C; Mathebula T; de Assis Rosa D; Mashishi T; Seoighe C; Ngandu N; van Loggerenberg F; Morris L; Mlisana K; Williamson C; Karim SA;
J Virol; 2009 Jan; 83(1):470-8. PubMed ID: 18945774
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.
Clark SA; Martin SL; Pozniak A; Steel A; Ward B; Dunning J; Henderson DC; Nelson M; Gazzard B; Kelleher P
Clin Exp Immunol; 2007 Nov; 150(2):238-44. PubMed ID: 17672869
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
Whiteside TL; Zhao Y; Tsukishiro T; Elder EM; Gooding W; Baar J
Clin Cancer Res; 2003 Feb; 9(2):641-9. PubMed ID: 12576430
[TBL] [Abstract][Full Text] [Related]
15. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
[TBL] [Abstract][Full Text] [Related]
16. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators.
Zhang W; Caspell R; Karulin AY; Ahmad M; Haicheur N; Abdelsalam A; Johannesen K; Vignard V; Dudzik P; Georgakopoulou K; Mihaylova A; Silina K; Aptsiauri N; Adams V; Lehmann PV; McArdle S
J Immunotoxicol; 2009 Dec; 6(4):227-34. PubMed ID: 19908941
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
18. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.
Boulet S; Ndongala ML; Peretz Y; Boisvert MP; Boulassel MR; Tremblay C; Routy JP; Sekaly RP; Bernard NF
J Immunol Methods; 2007 Mar; 320(1-2):18-29. PubMed ID: 17222422
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
Rutebemberwa A; Currier JR; Jagodzinski L; McCutchan F; Birx D; Marovich M; Cox JH
AIDS; 2005 Jul; 19(11):1165-72. PubMed ID: 15990569
[TBL] [Abstract][Full Text] [Related]
20. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
